The JDRF Center of Excellence in New England will accelerate beta cell replacement therapy
Harvard Stem Cell Institute (HSCI) co-director Douglas Melton, Ph.D., will lead a new multi-institutional center funded by JDRF to advance type 1 diabetes research. The JDRF Center of Excellence in New England will focus on the transplantation of beta cells, the insulin-producing cells of the pancreas that are attacked by the immune system during type 1 diabetes.
The center is also led by JDRF scientific staff leader Esther Latres, Ph.D. Other collaborators include...
Applications for 2018 Joslin Pilot & Feasibility grants now open to all Harvard/Affiliates.
The goal of the Pilot and Feasibility Study Program is to encourage research on diabetes and its complications by two target groups: young researchers in these fields who have not yet received significant NIH or other funding, and seasoned investigators either entering the diabetes field for the first time or exploring a completely new direction.
The program has been highly successful since its inception. Projects funded in past years...
This scanning electron microscope image shows the T cell-trapping biomaterial up-close with cavities and ducts allowing the entry, as well as movement and binding of autoimmune T cells in its interior. Photo courtesy of James Weaver.